Booster shots just add to McKesson’s appeal

Article Excerpt

Shares of drug wholesaler McKesson hit an all-time high of $375 in August 2022. That’s largely due to its role in distributing COVID-19 vaccines. The U.S. government just extended this deal through July 2023, which will help the company profit from the rollout of booster shots. McKesson also continues to boost your returns with share buybacks and higher dividends. MCKESSON CORP. $349 is a buy. The company (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 143.7 million; Market cap: $50.2 billion; Price-to-sales ratio: 0.2; Dividend yield: 0.6%; TSINetwork Rating: Above Average; www.mckesson.com) is the largest wholesale drug distributor in the U.S. and Canada. It also distributes surgical tools to hospitals, and operates the Rexall drugstore chain in Canada. In the past few years, McKesson has narrowed its focus to its main North American operations. Under that plan, in 2020 the company spun off its shares in its joint venture Change Healthcare Inc. (Nasdaq symbol CHNG). That firm makes software to help hospitals,…